RecruitingNot ApplicableNCT06439875

Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation.

Effects of the Association of L-arginine and Liposomal Vitamin C on Fatigue in COPD Patients With Chronic Respiratory Failure After Rehabilitation Intervention


Sponsor

Istituti Clinici Scientifici Maugeri SpA

Enrollment

102 participants

Start Date

Jul 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The hypothesis that is being tested is that the supplementation of L-arginine plus Vitamin C to multidisciplinary pulmonary rehabilitation (PR) in patients with a previous diagnosis of chronic obstructive pulmonary disease (COPD) and chronic respiratory failure can have a favorable influence on fatigue and on clinical indicators related to endothelial function, potentially mitigating the cardiovascular (CV) disease burden in this clinical context.


Eligibility

Min Age: 40 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether taking L-arginine (an amino acid) and liposomal Vitamin C (a highly absorbable form of Vitamin C) can help people with severe COPD (chronic obstructive pulmonary disease — a serious lung condition that makes breathing very difficult) do better during a breathing rehabilitation program. **You may be eligible if...** - You have severe COPD with low blood oxygen levels while breathing normal air - You are between 40 and 90 years old - You are enrolled in a pulmonary rehabilitation program at one of 12 Italian hospitals **You may NOT be eligible if...** - You have taken ergogenic (performance-enhancing) supplements in the last 2 months - You had a severe COPD flare-up in the last 3 months - You have heart disease, heart failure, major heart rhythm problems, or a recent blood clot in the lungs - You have a neuromuscular disease, orthopaedic condition that limits exercise, or significant memory problems Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTeffect of L-arginine and liposomial vitamin C on pulmonary rehabilitation

Patients with a certified diagnosis of COPD and chronic respiratory failure will be randomized in a 1:1 ratio into the interventional arm or the placebo controller arm. All patients will undergo multidisciplinary intensive pulmonary rehabilitation for 28 days. The patients in the interventional group will receive a twice-daily oral supplementation with either a combination of 1.66 g l-arginine plus 500 mg liposomal vitamin C

OTHERplacebo

Patients in this arm will undergo multidisciplinary intensive pulmonary rehabilitation without any dietary supplementation.


Locations(3)

Istituti Clinici Scientifici Maugeri Irccs

Telese Terme, Benevento, Italy

Istituti Clinici Scientifici Maugeri IRCCS

Lumezzane, Brescia, Italy

Istituti Clinici Scientifici Maugeri IRCCS

Bari, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06439875


Related Trials